← Back to Search

Behavioural Intervention

StimaWell 120MTRS system for Lower Back Pain

N/A
Waitlist Available
Research Sponsored by Concordia University, Montreal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before and 15 minutes after 3rd treatment
Awards & highlights

Study Summary

This trial will study the effects of a 10-week intervention using the StimaWELL 120MTRS device on the muscle structure and function of people with chronic low back pain. The study will also look at the acute effect of a single treatment with the StimaWELL 120MTRS on the stiffness of the multifidus muscle in people with chronic low back pain.

Eligible Conditions
  • Lower Back Pain
  • Paraspinal Muscles

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before and 15 minutes after 3rd treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and before and 15 minutes after 3rd treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in multifidus muscle fat infiltration
Change in multifidus muscle function (% thickness change)
Change in multifidus muscle size (cross-sectional area)
+1 more
Secondary outcome measures
Pain
Change in the Numerical Pain Rating Scale (NPRS) for low back pain intensity (best and worst pain over previous week)
Change in the Numerical Pain Rating Scale (NPRS) for low back pain intensity (sitting and with movement over past 24h)
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Phasic Treatment GroupExperimental Treatment1 Intervention
Muscle therapy for the lumbar spine at the StimaWell 120MTRS system's phasic setting. Treatment at 3 kHz, modulation 50 Hz. Supervised 10 week intervention, 2 times a week. Treatment time of 20 minutes for the first 3 weeks, 25 minutes for the second 3 weeks, and 30 minutes for the final 4 weeks. 120MTRS system recalibration every fifth treatment.
Group II: Combined Treatment GroupExperimental Treatment1 Intervention
Muscle therapy for the lumbar spine at the StimaWell 120MTRS system's combined (tonic and phasic) setting. Treatment at 3 kHz, modulation 4 Hz and 50 Hz. Supervised 10 week intervention, 2 times a week. Treatment time of 20 minutes for the first 3 weeks, 25 minutes for the second 3 weeks, and 30 minutes for the final 4 weeks. 120MTRS system recalibration every fifth treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
StimaWell 120MTRS system
2021
N/A
~30

Find a Location

Who is running the clinical trial?

Concordia University, MontrealLead Sponsor
22 Previous Clinical Trials
4,637 Total Patients Enrolled
MitacsIndustry Sponsor
38 Previous Clinical Trials
4,331 Total Patients Enrolled

Media Library

StimaWell 120MTRS system (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04891692 — N/A
Lower Back Pain Research Study Groups: Combined Treatment Group, Phasic Treatment Group
Lower Back Pain Clinical Trial 2023: StimaWell 120MTRS system Highlights & Side Effects. Trial Name: NCT04891692 — N/A
StimaWell 120MTRS system (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04891692 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this protocol accept participants aged 30 or older?

"This clinical trial is available to those aged 18 - 60. For younger and older patients, there are 11 trials for minors and 263 studies open to senior citizens."

Answered by AI

Who is the ideal participant for this research project?

"This medical trial seeks 30 participants aged 18 to 60 who suffer from chronic lower back agony. Qualified individuals must also fulfill the following prerequisites: score a minimum of 4/10 on an 11-point Numerical Pain Rating Scale (NPRS) for pain intensity, experience 'moderate' Modified Oswestry Disability Index (ODI), and be able to undergo MRI exam; furthermore, they need to speak either English or French. The selection criteria will take into account current pain as well as best and worst experiences over the preceding seven days."

Answered by AI

What goals are being sought after in this experiment?

"This trial has the primary goal of measuring changes in multifidus muscle stiffness over a 10 week baseline. Secondary objectives include gauging alterations to participants' Numerical Pain Rating Scale (NPRS) for present and past-week low back pain intensity, as well as assessing fluctuations on their Pain Catastrophizing Scale (PCS). The NPRS utilises a 0 - 10 scale, with zero representing no pain and ten being unbearable anguish; while PCS is scored from 0 - 4 per item, totalling 52 points – higher scores indicate more pessimism about one's condition."

Answered by AI

Is there any capacity for additional participants in this research?

"Affirmative. The clinicaltrial.gov website reports that this medical trial is actively recruiting participants, with the initial posting on February 22nd 2021 and most recent update on July 26th 2022. 30 individuals need to be enrolled at one particular location."

Answered by AI

What is the total number of participants enrolled in this experiment?

"Affirmative. Clinicaltrials.gov reports that, since its inception on February 22nd 2021, this clinical trial has been actively recruiting participants from one location with a goal of enrolling 30 patients."

Answered by AI
~7 spots leftby Apr 2025